Hermetica Superfood Encyclopedia
The Short Answer
Red wine delivers a complex matrix of phenolic bioactives—including anthocyanins (malvidin-3-glucoside), flavan-3-ols (catechin), hydroxycinnamic acids (caftaric acid), and stilbenes (resveratrol)—that collectively scavenge reactive oxygen species, modulate SIRT1 and Nrf2 signaling, and inhibit lipid peroxidation through multi-target antioxidant mechanisms. Observational epidemiological data associate moderate red wine consumption (200–300 mL/day) with reduced all-cause and cardiovascular mortality, while in vitro studies demonstrate red wine DPPH radical scavenging IC50 values as low as 2.676 µL/mL—approximately four-fold more potent than white wine—correlating directly with total phenolic content ranging from 733 to 2,500 mg/L GAE.
CategoryOther
GroupFermented/Probiotic
Evidence LevelPreliminary
Primary Keywordwine health benefits
Wine — botanical close-up
Health Benefits
**Antioxidant Activity**
Red wine phenolics, particularly anthocyanins and catechins at concentrations of 22–375 mg/L, scavenge DPPH and hydroxyl radicals with IC50 values of 2.676–105 µg/mL, providing measurable antioxidant capacity that outperforms white wine by approximately six-fold in comparative assays.
**Cardiovascular Protection**
Moderate wine consumption is epidemiologically associated with improved lipid profiles and reduced LDL oxidation, largely attributed to resveratrol's SIRT1 activation and the anti-inflammatory effects of flavonols that collectively reduce endothelial dysfunction and platelet aggregation.
**Anti-Inflammatory Effects**
Resveratrol and hydroxycinnamic acids in red wine activate the Nrf2 antioxidant response element and suppress NF-κB–mediated pro-inflammatory cytokine production, attenuating systemic low-grade inflammation observed in metabolic and cardiovascular disease states.
**DNA Protection (Antigenotoxicity)**
Red wine polyphenols protect plasmid DNA from oxidative strand breaks in vitro, with IC50 values of 2.312 µL/mL for red wine versus 17.66 µL/mL for white wine, suggesting that higher phenolic content confers proportionally greater genomic protection against ROS-induced damage.
**Gut Microbiota Modulation**
Wine phenolics, particularly proanthocyanidins and catechins, act as prebiotics for beneficial gut bacteria including Lactobacillus and Bifidobacterium species, and gut microbial metabolism of these polyphenols generates bioavailable metabolites such as urolithins and phenolic acids with independent bioactivity.
**Neuroprotective Potential**
Resveratrol in wine activates SIRT1 deacetylase and promotes autophagy, pathways linked to clearance of amyloid-beta aggregates in preclinical Alzheimer's models; epidemiological studies suggest moderate wine drinkers exhibit lower rates of cognitive decline, though confounding factors limit causal inference.
**Antimicrobial Properties**
Phenolic acids and flavonoids in wine, including p-coumaric acid and catechins, disrupt bacterial cell membranes and inhibit biofilm formation in vitro against pathogens such as Staphylococcus aureus and Helicobacter pylori, consistent with historical use of wine as a wound antiseptic.
Origin & History
Natural habitat
Wine is produced from the fermented juice of grapes belonging to the species Vitis vinifera, cultivated across Mediterranean Europe, the Middle East, North Africa, and the Americas, with origins traced to the South Caucasus region (modern Georgia and Armenia) approximately 8,000 years ago. Red wine varieties such as Vranec, Cabernet Sauvignon, and Xinomavro are grown in continental and Mediterranean climates with well-drained soils, where terroir, vine stress, and canopy management significantly influence berry phenolic content. Traditional viticulture and winemaking practices—including maceration duration, fermentation temperature, and the use of whole grape clusters with skins and seeds—govern the final concentration of bioactive polyphenols in the finished product.
“Wine holds one of the longest continuous records of medicinal use of any fermented beverage, with archaeological evidence of intentional fermentation in Georgia (Kvevri clay vessels, ~6000 BCE) and Egypt (~3100 BCE). Hippocrates (460–370 BCE) systematically prescribed wine for febrile illness, wound cleansing, and digestive complaints, recommending specific varieties diluted with water at different temperatures depending on the condition—an early recognition of what we now understand to be antimicrobial and anti-inflammatory phenolics. In Islamic medicine, figures such as Avicenna (Ibn Sina, 980–1037 CE) documented wine's analgesic, digestive, and wound-healing properties in the Canon of Medicine despite religious prohibition of consumption, acknowledging its pharmacological utility. Across European monastic traditions, wine production was preserved and advanced by Benedictine and Cistercian monks who cultivated specific varietals for sacramental and medicinal use, ultimately establishing the viticultural regions of Burgundy, Champagne, and the Rhine Valley.”Traditional Medicine
Scientific Research
The evidence base for wine's health effects is dominated by in vitro antioxidant assays and large observational/epidemiological cohort studies rather than randomized controlled trials (RCTs), limiting causal conclusions. Comparative phenolic analyses across multiple wine varieties (Macedonian Stanušina, Vranec, Cabernet Sauvignon; Greek Xinomavro, Monemvassia) consistently demonstrate that red wines contain 733–2,500 mg/L GAE total phenolics versus 200–500 mg/L in whites, with reproducible radical-scavenging IC50 relationships across independent laboratories. No large-scale RCTs specifically testing moderate wine consumption as an intervention against hard cardiovascular or mortality endpoints have been published with quantified effect sizes; the oft-cited J-shaped mortality curve derives from observational meta-analyses susceptible to confounding by healthy-user bias and abstainer misclassification. Isolated bioactive studies—particularly on resveratrol supplementation at doses far exceeding wine-achievable concentrations—show metabolic and anti-inflammatory effects in small RCTs (n=20–100), but these findings cannot be directly extrapolated to whole wine consumption.
Preparation & Dosage
Traditional preparation
**Whole Red Wine (Traditional consumption)**
150–300 mL/day (1–2 standard glasses) associated with observational cardiovascular benefits; preferred form for polyphenol synergy with alcohol as bioavailability enhancer
**Extended Maceration Red Wine**
Phenolic extraction peaks between days 3–9 of skin contact; anthocyanins maximize around day 6, catechins around day 9—winemakers targeting functional phenolics use 7–10 day cold soaks.
**Grape Pomace/Stem Extracts (Supplement form)**
100–300 mg/day of extract
Standardized to 40–95% total polyphenols or 5–50% oligomeric proanthocyanidins (OPCs); typical supplemental dose .
**Resveratrol Supplements (Isolated wine bioactive)**
100–500 mg/day in clinical studies; poorly bioavailable in free form (<1%), improved with piperine co-administration or liposomal/micronized formulations
**Red Wine Extract Capsules**
200 mg GAE per capsule; DPPH IC50 of commercial extracts reported at 31–105 µg/mL; take with meals to slow gastric transit and improve absorption
Standardized to total phenolics ≥.
**De-alcoholized Red Wine**
Retains >90% of phenolic content; an option for those avoiding alcohol; bioavailability of polyphenols may be slightly reduced without ethanol as a solubilizer.
**Timing Note**
Phenolic absorption is enhanced when consumed with or shortly after meals high in dietary fat, which promotes micelle-mediated intestinal uptake.
Nutritional Profile
Red wine (per 150 mL serving) provides approximately 125 kcal, 3.8 g carbohydrates (primarily residual sugars and glycerol), 0.1 g protein, and 0 g fat, with ethanol contributing ~14 g (12% ABV). Micronutrients include potassium (187 mg), magnesium (18 mg), iron (0.68 mg), and trace amounts of B vitamins (riboflavin 0.03 mg, niacin 0.28 mg). Phytochemical content is dominated by total phenolics at 733–2,500 mg/L GAE in reds, with principal classes including anthocyanins (22–577 mg/L, primarily malvidin-3-glucoside), flavan-3-ols (20–375 mg/L catechin equivalents), hydroxycinnamic acids (224–511 mg/L, mainly caftaric and caffeic acid), flavonols (quercetin, myricetin, 10–50 mg/L), and trans-resveratrol (0.1–14 mg/L depending on variety and vintage). Bioavailability of wine polyphenols is generally low to moderate: anthocyanin absorption is 5–10%, hydroxycinnamic acids 20–30%, and resveratrol 70% but subject to rapid phase II conjugation and enterohepatic recycling; gut microbiota metabolism is essential for generating bioavailable phenolic acid metabolites from polymeric tannins.
How It Works
Mechanism of Action
Wine phenolics act as direct free-radical scavengers by donating hydrogen atoms or electrons to reactive oxygen species (ROS), with the ortho-dihydroxyl structure of catechins and anthocyanins being critical for radical stabilization, as quantified by DPPH and FRAP assays where total phenolic content strongly predicts antioxidant capacity. Resveratrol, a stilbene present in red wine, allosterically activates the NAD+-dependent deacetylase SIRT1, which subsequently promotes PGC-1α–mediated mitochondrial biogenesis and downregulates NF-κB–driven inflammatory gene expression, while simultaneously activating the Nrf2/Keap1 pathway to upregulate endogenous antioxidant enzymes including superoxide dismutase, catalase, and glutathione peroxidase. Anthocyanins such as malvidin-3-glucoside interact with platelet surface receptors and inhibit ADP-induced aggregation, while proanthocyanidins chelate transition metals (Fe²⁺, Cu²⁺) to prevent Fenton-reaction–mediated hydroxyl radical generation and lipid peroxidation in cellular membranes. Gut microbial metabolism converts polymeric wine polyphenols into smaller, more bioavailable metabolites—including urolithins, valerolactones, and phenolic acids—that access systemic circulation and exert secondary anti-inflammatory and epigenetic effects beyond what is achievable from the parent compounds alone.
Clinical Evidence
Clinical evidence for wine as a health-promoting beverage rests primarily on epidemiological associations rather than controlled interventional data. Large prospective cohort studies report a J-shaped relationship between wine consumption and all-cause mortality, with moderate intake (one to two glasses per day, approximately 200–300 mL) associated with 20–30% reduced relative risk of cardiovascular events compared to abstainers, though residual confounding from socioeconomic status, diet, and lifestyle represents a significant limitation. Mechanistic human studies measuring postprandial antioxidant status, platelet function, and flow-mediated vasodilation after acute wine ingestion report statistically significant improvements compared to water or de-alcoholized wine controls, implicating phenolics rather than alcohol alone in some benefits. RCTs targeting isolated wine polyphenols such as resveratrol (100–500 mg/day) show modest improvements in insulin sensitivity and inflammatory biomarkers in metabolic syndrome populations, but whole-wine RCTs with hard clinical endpoints remain absent, placing overall confidence in causal benefit at a low-to-moderate level.
Safety & Interactions
At moderate consumption levels (≤200–300 mL/day for adults), wine is generally well tolerated, but ethanol is a schedule I carcinogen classified by the IARC with no established safe threshold for cancer risk; even moderate intake is associated with increased risk of breast, colorectal, oral, and esophageal cancers in dose-dependent fashion. Significant drug interactions arise from ethanol's inhibition of cytochrome P450 enzymes (CYP2E1, CYP3A4), potentiating sedative-hypnotics, benzodiazepines, opioids, and metronidazole (disulfiram-like reaction); wine polyphenols additionally inhibit CYP3A4 and CYP1A2, potentially elevating plasma concentrations of statins, calcium channel blockers, and certain anticoagulants including warfarin. Tyramine content in red wines (up to 25 mg/L) poses a risk of hypertensive crisis for individuals taking monoamine oxidase inhibitors (MAOIs), and sulfites used as preservatives (10–200 mg/L) can trigger bronchospasm in sulfite-sensitive individuals, particularly those with asthma. Wine is absolutely contraindicated during pregnancy (fetal alcohol spectrum disorders), in individuals with alcohol use disorder, liver cirrhosis, pancreatitis, or severe hypertriglyceridemia, and in those taking disulfiram, naltrexone, or metronidazole.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Wine (Vitis vinifera fermented beverage)vingrape wineoinosvinoVitis vinifera fermented beverage
Frequently Asked Questions
What are the main health benefits of drinking red wine?
Red wine's primary health benefits stem from its phenolic compounds—anthocyanins, catechins, resveratrol, and hydroxycinnamic acids—present at 733–2,500 mg/L GAE, which collectively scavenge reactive oxygen species, reduce LDL oxidation, and modulate inflammatory pathways via SIRT1 and Nrf2 activation. Epidemiological data associate moderate consumption of 200–300 mL/day with approximately 20–30% reduced relative risk of cardiovascular events, though these findings are observational and subject to confounding, meaning causality has not been established through randomized controlled trials.
How much wine per day is considered healthy?
Most epidemiological research links moderate intake—defined as one standard glass (150 mL) for women and up to two glasses (300 mL) for men per day—with the lowest all-cause mortality in J-shaped curve analyses, while consumption above 300 mL/day is associated with increasing risks of liver disease, cancer, and cardiovascular harm. It is critical to note that the IARC classifies ethanol as a Group 1 carcinogen with no established safe threshold for cancer risk, so any recommendation for 'healthy' consumption must weigh cardiovascular phenolic benefits against oncological risk, particularly for breast and colorectal cancers.
Does red wine have more antioxidants than white wine?
Yes, red wine contains approximately six times more phenolic antioxidants than white wine because red wine is fermented with grape skins and seeds, which are the primary repositories of anthocyanins, tannins, and catechins; red wines measure 733–2,500 mg/L GAE total phenolics compared to 200–500 mg/L in whites. This difference is reflected in radical-scavenging assays, where red wine DPPH IC50 values average 2.676 µL/mL versus 10.45 µL/mL for white wine, indicating roughly four-fold greater potency per unit volume.
What is resveratrol and is there enough in wine to be beneficial?
Resveratrol is a stilbene polyphenol in red wine—present at 0.1–14 mg/L depending on variety, vintage, and production method—that activates the longevity-associated deacetylase SIRT1, suppresses NF-κB–mediated inflammation, and upregulates endogenous antioxidant enzymes via the Nrf2 pathway. Clinical studies demonstrating metabolic and anti-inflammatory benefits have used supplemental resveratrol doses of 100–500 mg/day, which would require drinking 7–500 liters of wine daily to match, meaning that wine alone cannot deliver clinically therapeutic resveratrol concentrations and its benefits likely arise from the synergistic action of its entire polyphenol matrix rather than resveratrol alone.
Is wine safe to drink with medications?
Wine poses clinically significant drug interaction risks through two mechanisms: ethanol inhibits and then induces CYP2E1 and CYP3A4 enzymes, altering metabolism of statins, benzodiazepines, opioids, anticoagulants (especially warfarin), and acetaminophen; and wine polyphenols independently inhibit CYP1A2 and CYP3A4, potentially raising plasma levels of caffeine, theophylline, and calcium channel blockers. Additionally, tyramine in red wine (up to 25 mg/L) can precipitate hypertensive crisis in patients taking monoamine oxidase inhibitors (MAOIs), and wine is absolutely contraindicated with disulfiram and metronidazole due to the risk of a severe acetaldehydemia reaction.
What are the main phenolic compounds in wine and which ones provide the most antioxidant benefit?
Wine contains several key phenolic compounds including anthocyanins and catechins, which exist at concentrations of 22–375 mg/L depending on the wine type and production method. These compounds demonstrate measurable antioxidant capacity with IC50 values of 2.676–105 µg/mL in radical scavenging assays, with red wine phenolics showing approximately six-fold greater antioxidant activity compared to white wine. Anthocyanins, which give red wine its color, are among the most potent contributors to its antioxidant profile. The specific phenolic composition varies based on grape variety, fermentation duration, and aging conditions.
Is wine an effective dietary source of antioxidants compared to other beverages and foods?
Wine provides a concentrated source of phenolic antioxidants, with red wine delivering substantially higher levels than white wine due to extended skin contact during fermentation. However, the antioxidant benefit from wine must be weighed against alcohol content and caloric density; other sources like grape juice, berries, and tea can provide similar polyphenol levels without alcohol. The bioavailability and absorption of wine phenolics in the human body may differ from isolated compounds studied in laboratory assays. For antioxidant benefits, whole food sources like grapes, pomegranates, and dark berries are often recommended as alternatives with lower alcohol exposure.
Who should avoid consuming wine or wine-based supplements due to health conditions or sensitivities?
Individuals with alcohol use disorder, liver disease, certain cancers (particularly breast cancer), and those taking medications that interact with alcohol should avoid wine consumption entirely. Pregnant and breastfeeding women are advised against wine consumption due to potential fetal alcohol effects and passage of alcohol into breast milk. People with histamine sensitivity, sulfite allergies, or certain digestive conditions may experience adverse reactions to wine's natural compounds and additives. Those with uncontrolled blood pressure, migraines triggered by alcohol, or on medications requiring alcohol avoidance should consult healthcare providers before consuming wine.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w wine-vitis-vinifera-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
